Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung Disease
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the safety, tolerability and preliminary
efficacy of two dose levels of INS37217 (denufosol tetrasodium) Inhalation Solution in
patients with cystic fibrosis (CF) lung disease.